Kepp, O;Senovilla, L;Vitale, I;Vacchelli, E;Adjemian, S;Agostinis, P;Apetoh, L;Aranda, F;Barnaba, V;Bloy, N;Bracci, L;Breckpot, K;Brough, D;Buque, A;Castro, MG;Cirone, M;Colombo, MI;Cremer, I;Demaria, S;Dini, L;Eliopoulos, AG;Faggioni, A;Formenti, SC;Fucikova, J;Gabriele, L;Gaipl, US;Galon, J;Garg, A;Ghiringhelli, F;Giese, NA;Guo, ZS;Hemminki, A;Herrmann, M;Hodge, JW;Holdenrieder, S;Honeychurch, J;Hu, HM;Huang, X;Illidge, TM;Kono, K;Korbelik, M;Krysko, DV;Loi, S;Lowenstein, PR;Lugli, E;Ma, YT;Madeo, F;Manfredi, AA;Martins, I;Mavilio, D;Menger, L;Merendino, N;Michaud, M;Mignot, G;Mossman, KL;Multhoff, G;Oehler, R;Palombo, F;Panaretakis, T;Pol, J;Proietti, E;Ricci, JE;Riganti, C;Rovere-Querini, P;Rubartelli, A;Sistigu, A;Smyth, MJ;Sonnemann, J;Spisek, R;Stagg, J;Sukkurwala, AQ;Tartour, E;Thorburn, A;Thorne, SH;Vandenabeele, P;Velotti, F;Workenhe, ST;Yang, HN;Zong, WX;Zitvogel, L;Kroemer, G;Galluzzi, L
Consensus guidelines for the detection of immunogenic cell death
Oncoimmunology
2014
3
9
e955691-

Lemke, Dieter;Weiler, Markus;Blaes, Jonas;Wiestler, Benedikt;Jestaedt, Leonie;Klein, Ann-Catherine;Löw, Sarah;Eisele, Günter;Radlwimmer, Bernhard;Capper, David;Schmieder, Kirsten;Mittelbronn, Michel;Combs, Stephanie E;Bendszus, Martin;Weller, Michael;Platten, Michael;Wick, Wolfgang
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
J Neurochem
2014
131
2
251-64

Vaidya, Jayant S;Wenz, Frederik;Bulsara, Max;Tobias, Jeffrey S;Joseph, David J;Keshtgar, Mohammed;Flyger, Henrik L;Massarut, Samuele;Alvarado, Michael;Saunders, Christobel;Eiermann, Wolfgang;Metaxas, Marinos;Sperk, Elena;Sütterlin, Marc;Brown, Douglas;Esserman, Laura;Roncadin, Mario;Thompson, Alastair;Dewar, John A;Holtveg, Helle M R;Pigorsch, Steffi;Falzon, Mary;Harris, Eleanor;Matthews, April;Brew-Graves, Chris;Potyka, Ingrid;Corica, Tammy;Williams, Norman R;Baum, Michael
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
Lancet
2014
383
9917
603-13

Vorwerk, H;Zink, K;Schiller, R;Budach, V;Böhmer, D;Kampfer, S;Popp, W;Sack, H;Engenhart-Cabillic, R
Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.
Strahlenther Onkol
2014
190
5
433-43

Duma, M N;Molls, M;Trott, K R
From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy.
Strahlenther Onkol
2014
190
1
5-7

Dellas, Kathrin;Vonthein, Reinhard;Zimmer, Jörg;Dinges, Stefan;Boicev, Alexander D;Andreas, Peter;Fischer, Dorothea;Winkler, Cornelia;Ziegler, Andreas;Dunst, Jürgen
Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01).
Strahlenther Onkol
2014
190
7
646-53

Gaipl, Udo S;Multhoff, Gabriele;Scheithauer, Heike;Lauber, Kirsten;Hehlgans, Stefanie;Frey, Benjamin;Rödel, Franz
Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.
Immunotherapy
2014
6
5
597-610

Borm, K J;Oechsner, M;Wilkens, J J;Berndt, J;Molls, M;Geinitz, H;Duma, M N
The impact of CT window settings on the contouring of a moving target: A phantom study.
Clin Radiol
2014
69
8
e331-6

Gehrmann, Mathias;Cervello, Melchiorre;Montalto, Giuseppe;Cappello, Francesco;Gulino, Alessandro;Knape, Clemens;Specht, Hanno M;Multhoff, Gabriele
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Front Immunol
2014
5
307

Nüsslin, Fridtjof
in.nrw--Innovating medical technology: a research platform to advance patient-adapted health care--the cluster "Patient Customized Engineering for Smart Cardiovascular Therapy".
Biomed Tech (Berl)
2014
59
2
87-9